Galectin Therapeutics Inc
GALT· Nasdaq
GALTGalectin Therapeutics Inc
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001140361-23-039411
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$9.11M | -$9.61M | -$8.45M | -$6.11M |
| EPS Diluted | -$0.15 | -$0.16 | -$0.15 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Galectin Therapeutics Inc · CIK 1133416 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end
